Veozah
Payments companies reported to CMS as associated with Veozah. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Veozah, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Veozah
These are the largest totals companies reported as associated with Veozah. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jennifer Ashton | Englewood, NJ | Obstetrics & Gynecology | $1,319,134.33 |
| Risa Kagan | Berkeley, CA | Obstetrics & Gynecology | $225,034.82 |
| Alyse Kelly Jones | Charlotte, NC | Gynecology | $222,093.92 |
| Corey Babb | Tulsa, OK | Gynecology | $163,769.57 |
| Richard Payne | Encinitas, CA | Family Medicine | $126,244.35 |
| Jessica Shepherd | Dallas, TX | Gynecology | $124,197.10 |
| Steven Goldstein | New York, NY | Obstetrics & Gynecology | $105,169.49 |
| Kamilia Smith | Dallas, TX | Obstetrics & Gynecology | $102,326.82 |
| Lisa Eng | New York, NY | Obstetrics & Gynecology | $95,619.29 |
| Gloria Richard-Davis | Little Rock, AR | Reproductive Endocrinology | $94,057.68 |
Prescribed Veozah?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.